Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese patent medicine pills for treating hepatitis B

A technology for Chinese patent medicine and hepatitis B, which is applied in the field of Chinese patent pills for treating hepatitis B, can solve problems such as unsatisfactory treatment, and achieve the effects of no toxic and side effects, good therapeutic effect, and improved immunity.

Active Publication Date: 2013-11-27
刘新江
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, there are many hepatitis B diseases in various regions of our country, especially children seek medical treatment everywhere, and cannot get ideal treatment, which brings a kind of mental pressure and pain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0010] Example 1: Yu Moumou: male, 60 years old, had hepatitis B minor yang ten years ago, and the hepatitis B virus (HBA-DNA) gene was 3×10 5 Copies / ml, after four years of treatment in large and small hospitals, no improvement. I came to see a doctor on July 1, 2007, when the hepatitis B virus (HBV-DNA) gene was still 2 × 10 5 Copies / ml, taking medicine for 80 days, reexamination in April 2008, hepatitis B virus (HBV-DNA) gene turned negative, still small three yang, hepatitis B virus (HBV-DNA) gene is still negative in the past four years, still small three positive, no relapse. In June 2002, the reexamination found that the five indicators of hepatitis B two and a half turned negative naturally.

example 2

[0011] Example 2: Pan Moumou: Male, 32 years old, suffered from hepatitis B and three genitals in January 2010, and did not get better with medication in large and small hospitals. He came to see a doctor on July 21, 2012. 8 copy / ml,) the liver function is not normal for a long time, the transaminase is 234U / L, the total bilirubin is 34Umol / L, and the medicine is taken here for 150 days. Re-examination on December 21, 2012, the big three yangs turned into small three yangs, and the hepatitis B virus (HBV-DNA) gene was changed to 1.36×10 4 Copies / ml, liver function was not tested. On December 21, 2012, the drug was discontinued after 30 days. On March 5, 2013, the reexamination showed that the liver function was normal, and the hepatitis B virus (HBV-DNA) gene was transgenic, and it was still small three yang.

example 3

[0012] Example 3: Liu Moumou: male, 63 years old, he and his family have suffered from hepatitis B and three genitals for many years, and his liver function has been abnormal for a long time. DNA) gene is 2×10 7 copies / ml, abnormal liver function, including transaminase 700U / L, total bilirubin 70Umol / L, medication for 120 days, liver function improved significantly in May 2009, turned into small three yang, hepatitis B virus (HBV-DNA) Genes are 2×10 5 Copies / ml, continue to use for 1 month, reexamination of liver function is normal, hepatitis B virus (HBV-DNA) gene turned negative, 10 months after drug withdrawal, reexamination in November 2009, all five indicators of hepatitis B two and a half turned negative, Liver function was normal, followed up for four years, no recurrence.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to Chinese patent medicine pills for treating hepatitis B. The pills are prepared from the raw materials in percentage by weight: 150-300g of lucid ganoderma, 350-700g of Artemisia lactiflora (Sijicai), 100-200g of Sculellaria barbata, 100-200g of Oldenlandia diffusa, 80-160g of Poria cocos, 80-160g of bock greenbrier rhizome (chinaroot greenbrier), 100-200g of radix sophorae flavescentis, 60-120g of fructus aurantii, 60-120g of Lysimachia christinae Hance, 50-100g of Prunella vulgaris and 100-200g of phyllanthus ruinaria. The Chinese patent medicine pills provided by the invention are prepared from pure traditional Chinese medicines, and are low in cost, economical and practical, free of toxic and side effects, good in treatment effect and high in cure rate, and can treat the hepatitis B.

Description

technical field [0001] The invention mainly focuses on traditional Chinese medicine pharmacy, and is specifically a Chinese patent medicine pill for treating hepatitis B. Background technique [0002] At present, there are many hepatitis B diseases in various regions of our country, especially children seek medical treatment everywhere, and cannot get ideal treatment, which brings a kind of mental pressure and pain. Contents of the invention [0003] In view of the above problems, the present invention is a Chinese patent medicine pill for treating hepatitis B, which can clear away heat and detoxify, promote blood circulation and remove blood stasis, invigorate the spleen, promote dampness, reduce enzymes, reduce jaundice, improve immunity, eliminate hepatitis B virus, and then achieve the purpose of turning overcast of hepatitis B. [0004] The present invention is prepared from the following weight ratio raw materials: Ganoderma lucidum 150g-300g Guangdong Liu Jinu (Four...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/90A61K36/896A61K9/20A61P31/20
Inventor 刘新江
Owner 刘新江
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com